2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
22
Neoplasms
20
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lymphoma
7
Lung Neoplasms
7
Hematologic Neoplasms
6
Glioblastoma
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leukemia
5
Fatigue
5
Stomach Neoplasms
4
Depression
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Carcinoma, Hepatocellular
3
Interventions
Metformin
8
Surveys and Questionnaires
3
Pioglitazone
3
Nutrition Assessment
3
Methods
3
Exercise
3
Educational Status
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Interviews as Topic
2
Glucose Tolerance Test
2
Biopsy
2
tocilizumab
1
tislelizumab
1
sofosbuvir-velpatasvir drug combination
1
saxagliptin
1
pembrolizumab
1
otelixizumab
1
nabiximols
1
esmolol
1
epalrestat
1
donafenib
1
dapagliflozin
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus
×
Palliative Care
×
Clear all
NCT04836221
2023-06-18
CARES
Medstar Health Research Institute
Phase NA
Completed
63 enrolled